Boswellia Colon Cancer Research Wins Award

CHICAGOResearch on Boswellia serrata extracts ability to inhibit colorectal cancer proved to be award winning for Ajay Goel, Ph.D., director of Epigenetics and Cancer Prevention at Baylor Research Institute in Dallas. He was recognized for his research at the International Meeting of the American Gastroenterological Association as a Poster of Distinction presented during Digestive Disease Week in Chicago, May 7 to 10.

 Boswellia has a dramatic impact on cancer and, in essence, can teach the body how to heal itself, Goel said. I am glad I can illuminate the promise of boswellia with my research. I was delighted that it was one of the top 5 percent of 18,000 entries to be awarded. This really is a rare honor."  

Goels work explored the ability of high-AKBA (acetyl-11-keto-β-boswellic acid) boswellia extract to inhibit tumor growth in colorectal cells. This research established that boswellia extract induces DNA demethylation, potentially preventing aberrant cell division. It helps reactivate the tumor-suppressing genes, which can put the body on a path toward healing itself. This research provided a more in-depth view of the mechanics of boswellia extracts natural cell-supporting activity.

Goel, who serves as a scientific advisory board member for EuroPharma used the companys BosPure® boswellia extract in his research.